Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction

NCT02206646 · clinicaltrials.gov ↗

COMPLETED

Status

987

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: Metalyse

Sponsor

Boehringer Ingelheim